Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nite Capital Management was a private equity and venture capital firm that specialized in providing financing to small-cap and micro-cap public companies, with a significant focus on the life sciences and biotechnology sectors. The firm was known for participating in Private Investment in Public Equity (PIPE) transactions, supporting early-to-mid-stage healthcare companies in their clinical development efforts. Its portfolio included numerous biopharmaceutical and medical device companies such as BioSante Pharmaceuticals, Manhattan Pharmaceuticals, and Xenomics. Nite Capital is currently considered inactive or out of business, having ceased its primary investment operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nite Capital.